Chronic Pain — Evaluation of Botox Treatment on Chronical Scrotal Pain
Citation(s)
Aljumaily A, Forbes E, Al-Khazraji HAJ, Gordon A, Lau S, Jarvi KA Frequency and severity of chronic scrotal pain in Canadian men presenting to urologists for infertility investigations. Transl Androl Urol. 2017 Dec;6(6):1150-1154. doi: 10.21037/tau.2017.11.28.
Aoki KR Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003 Jul-Aug;43 Suppl 1:S9-15. Review.
Benson JS, Abern MR, Larsen S, Levine LA Does a positive response to spermatic cord block predict response to microdenervation of the spermatic cord for chronic scrotal content pain? J Sex Med. 2013 Mar;10(3):876-82. doi: 10.1111/j.1743-6109.2012.02937.x. Epub 2012 Sep 27.
Calixte N, Brahmbhatt J, Parekattil S Genital pain: algorithm for management. Transl Androl Urol. 2017 Apr;6(2):252-257. doi: 10.21037/tau.2017.03.03. Review.
Colhado OC, Boeing M, Ortega LB Botulinum toxin in pain treatment. Rev Bras Anestesiol. 2009 May-Jun;59(3):366-81. Review. English, Portuguese.
Dindo D, Demartines N, Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.
Dockray J, Aljumaily A, Lau S, Jarvi KA A Randomized, Double-Blind, Controlled Trial Shows that Onabotulinum Toxin A Nerve Blocks do Not Provide Improved Pain Control in Men with Chronic Scrotal Pain. J Urol. 2020 Apr;203(4):767-772. doi: 10.1097/JU.0000000000000658. Epub 2019 Oct 18.
Khambati A, Lau S, Gordon A, Jarvi KA OnabotulinumtoxinA (Botox) nerve blocks provide durable pain relief for men with chronic scrotal pain: a pilot open-label trial. J Sex Med. 2014 Dec;11(12):3072-7. doi: 10.1111/jsm.12707. Epub 2014 Oct 6.
Kumar R Therapeutic use of botulinum toxin in pain treatment. Neuronal Signal. 2018 Aug 31;2(3):NS20180058. doi: 10.1042/NS20180058. eCollection 2018 Sep. Review.
Lee CL, Kuo HC Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Toxins (Basel). 2015 Oct 22;7(10):4283-93. doi: 10.3390/toxins7104283.
Nigam PK, Nigam A Botulinum toxin. Indian J Dermatol. 2010;55(1):8-14. doi: 10.4103/0019-5154.60343.
Park J, Park HJ Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins (Basel). 2017 Aug 24;9(9). pii: E260. doi: 10.3390/toxins9090260. Review.
Schover LR Psychological factors in men with genital pain. Cleve Clin J Med. 1990 Nov-Dec;57(8):697-700.
Sigalos JT, Pastuszak AW Chronic orchialgia: epidemiology, diagnosis and evaluation. Transl Androl Urol. 2017 May;6(Suppl 1):S37-S43. doi: 10.21037/tau.2017.05.23. Review.
Sim WS Application of botulinum toxin in pain management. Korean J Pain. 2011 Mar;24(1):1-6. doi: 10.3344/kjp.2011.24.1.1. Epub 2011 Feb 25.
Singh V, Sinha RJ Idiopathic chronic orchialgia - a frustrating issue for the clinician and the patient. Indian J Surg. 2008 Jun;70(3):107-10. doi: 10.1007/s12262-008-0032-x. Epub 2008 Jul 24.
Soares A, Andriolo RB, Atallah AN, da Silva EM Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev. 2014 Jul 25;(7):CD007533. doi: 10.1002/14651858.CD007533.pub3. Review.
Wu C, Jarvi K Management of chronic scrotal content pain. Can Urol Assoc J. 2018 Jun;12(6 Suppl 3):S164-S166. doi: 10.5489/cuaj.5326. Review.
Evaluation of Botox Treatment in Patients With Chronic Scrotal Pain: a Randomized Double Blinded Control Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
